Royal Biologics, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$1.8Mgeneral payments (2019-2025)
$111Kresearch payments (2019-2025)
643clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $135K
2020 $88K
2021 $286K
2022 $255K
2023 $210K
2024 $416K
2025 $390K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Orthopaedic Surgery of The Spine $531K
Orthopaedic Surgery $399K
Foot & Ankle Surgery $230K
Orthopaedic Trauma $217K
Neurological Surgery $191K
Plastic Surgery $78K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Grigoriy Arutyunyan Rochester, MN Orthopaedic Surgery $288,718.66
Brad Prybis Stockbridge, GA Orthopaedic Surgery of The Spine $168,909.96
Robert Wetzel Cleveland, OH Orthopaedic Trauma $154,844.58
Ki Hon Lin Carrollton, GA Orthopaedic Surgery of The Spine $137,879.57
Salvatore Zavarella West Islip, NY Neurological Surgery $128,186.62
Joseph Racanelli Morristown, NJ Plastic Surgery $75,650.00
Raz Winiarsky Brooklyn, NY Orthopaedic Surgery of The Spine $72,660.00
Frank Liporace Jersey City, NJ Orthopaedic Trauma $61,026.56
Olatunde Osofisan W Hempstead, NY Foot & Ankle Surgery $53,091.57
Sushil Basra Commack, NY Orthopaedic Surgery of The Spine $45,025.32

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.